These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21925153)

  • 1. Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype.
    Paige M; Burdick MD; Kim S; Xu J; Lee JK; Shim YM
    Biochem Biophys Res Commun; 2011 Oct; 413(4):588-93. PubMed ID: 21925153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
    Di Stefano A; Coccini T; Roda E; Signorini C; Balbi B; Brunetti G; Ceriana P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1691-1700. PubMed ID: 29872287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
    Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
    Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers.
    Chen Q; Deeb RS; Ma Y; Staudt MR; Crystal RG; Gross SS
    PLoS One; 2015; 10(12):e0143937. PubMed ID: 26674646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
    Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
    Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics-based search for lung cancer markers among patients with different smoking status.
    Klupczynska-Gabryszak A; Daskalaki E; Wheelock CE; Kasprzyk M; Dyszkiewicz W; Grabicki M; Brajer-Luftmann B; Pawlak M; Kokot ZJ; Matysiak J
    Sci Rep; 2024 Jul; 14(1):15444. PubMed ID: 38965272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease.
    Kamio K; Ishii T; Motegi T; Hattori K; Kusunoki Y; Azuma A; Gemma A; Kida K
    Geriatr Gerontol Int; 2013 Oct; 13(4):1069-75. PubMed ID: 23441714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.
    Bahr TM; Hughes GJ; Armstrong M; Reisdorph R; Coldren CD; Edwards MG; Schnell C; Kedl R; LaFlamme DJ; Reisdorph N; Kechris KJ; Bowler RP
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):316-23. PubMed ID: 23590301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
    Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
    COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
    Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
    Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD.
    Cruickshank-Quinn CI; Jacobson S; Hughes G; Powell RL; Petrache I; Kechris K; Bowler R; Reisdorph N
    Sci Rep; 2018 Nov; 8(1):17132. PubMed ID: 30459441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function.
    Occhipinti M; Paoletti M; Bigazzi F; Camiciottoli G; Inchingolo R; Larici AR; Pistolesi M
    Radiology; 2018 May; 287(2):683-692. PubMed ID: 29361243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.
    Kilk K; Aug A; Ottas A; Soomets U; Altraja S; Altraja A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of pathophysiological parameters between emphysematous smokers and emphysematous patients with COPD.
    Bai S; Ye R; Wang C; Sun P; Zhao L
    Sci Rep; 2020 Jan; 10(1):420. PubMed ID: 31942006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of alveolar wall cells in chronic obstructive pulmonary disease patients with pulmonary emphysema is involved in emphysematous changes.
    Liu H; Ma L; Wu J; Wang K; Chen X
    J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):466-9. PubMed ID: 19662364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
    Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Nambiar S; Tan DBA; Clynick B; Bong SH; Rawlinson C; Gummer J; Corte TJ; Glaspole I; Moodley YP; Trengove R
    Proteomics Clin Appl; 2021 May; 15(2-3):e2000039. PubMed ID: 33580915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smokers with COPD Show a Shift in Energy and Nitrogen Metabolism at Rest and During Exercise.
    Holz O; DeLuca DS; Roepcke S; Illig T; Weinberger KM; Schudt C; Hohlfeld JM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1-13. PubMed ID: 32021139
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.